LYMPHOMA, B-CELL

This study tested a new, more convenient schedule for radiation therapy given before CAR T-cell treatment. Ten adults with B-cell lymphoma that had returned or not responded to other treatments received radiation once a week for five weeks. The main goal was to see if this weekly…

This study tested a new cell therapy for adults whose B-cell blood cancers (like leukemia or lymphoma) came back or never fully went away after a donor stem cell transplant. Researchers collected immune cells from the original transplant donor, genetically engineered them to bett…

This study tested two different chemotherapy combinations (R-ACVBP and R-CHOP) for younger adults with aggressive B-cell lymphoma who had higher risk factors. The trial used PET scans after the 2nd and 4th treatment cycles to guide whether patients received standard consolidation…

This study tested the safety and initial effectiveness of a two-drug combination (favezelimab and pembrolizumab) for people with certain blood cancers, including Hodgkin lymphoma and non-Hodgkin lymphoma. It involved 137 participants to find a safe dose and see if the treatment c…

This study tested an oral medication called LOXO-305 in Chinese adults with certain types of lymphoma or chronic leukemia that had returned or stopped responding to standard treatments. The main goal was to see how safe the drug was and how well it worked to control the cancer. R…

This study tested whether a supervised weight training program could help people with lymphoma maintain muscle mass and strength while undergoing chemotherapy. Forty-two patients were randomly assigned to either follow the 4-month exercise program or receive usual care. Researche…

This study aims to gather information on how well a cancer treatment called CAR T-cell therapy works for people living with HIV who also have certain blood cancers. Researchers will collect standard medical data from about 30 patients who have already received this therapy. The g…